CMS Open Payments · Program Year 2024
Teleflex Medical Incorporated
Teleflex Medical Incorporated reported $268,812.45 across General Payments, Research, and Ownership to 24 physicians and teaching hospitals across 24 transactions.
- $268.8K Above-median payer
- All-tracks total
- 24 Below-median volume
- Transactions
- 24 Below-median reach
- Recipients
- −$16.8K
- General Payments vs PY2023
Teleflex Medical Incorporated reported $268,812.45 across all CMS Open Payments tracks (General + Research + Ownership) to 24 physicians and teaching hospitals in Program Year 2024 - ranking #912 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $268,812.45, averaging $11.2K per recipient.
Teleflex Medical Incorporated's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
24/100
Total payments
F
12/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
D
63/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer teleflex-medical-incorporated Teleflex Medical Incorporated
$268.8K · #912/1,925 · 0.0% industry · PY2024
- TOT $268.8K
- RANK #912
- SHARE 0.0%
- TXN 24
- RCP 24
- CAT 5
- GEN $268.8K
- ΔGEN −$16.8K
- TOP1 85.6%
- PY 2024
Volume peers
Nearest volume peer: Cranial Technologies, Inc ($268.9K)
Teleflex Medical Incorporated sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Teleflex Medical Incorporated's CMS-reported General Payments decreased by $16.8K (−5.9%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: TELEFLEX MEDICAL INCORPORATEDPY2023: TELEFLEX MEDICAL INCORPORATEDPY2024: Teleflex Medical Incorporated. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $285,630.97
- PY2024
- $268,812.45
What the Data Shows for Teleflex Medical Incorporated
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Teleflex Medical Incorporated that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
The 5-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Royalty or License" at $241.9K, accounting for 90.0% of this company's General Payments and 16 transactions.
General Payment Breakdown by Type
Across 5 types of general payments, Teleflex Medical Incorporated's largest category was "Royalty or License" at $241.9K - 90.0% of General Payments.
Teleflex Medical Incorporated reports 5 general-payment categories - the top three are Royalty or License (90.0%), Consulting Fee (6.4%), and Compensation for Services Other Than Consulting (3.3%). The remaining 2 categories make up 0.3% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Teleflex Medical Incorporated divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Royalty or License | $241.9K | 16 | 90.0% |
| Consulting Fee | $17.1K | 1 | 6.4% |
| Compensation for Services Other Than Consulting | $8.9K | 2 | 3.3% |
| Debt Forgiveness | $587.57 | 1 | 0.2% |
| Food and Beverage | $265.26 | 4 | 0.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $268,068.17 (99.7%) of $268,812.45 in this company's General Payments records across 7 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Teleflex Medical Incorporated
The five named recipients with the highest reported General Payments from this company
- 1
Sundaram Ravikumar
$230,029.67 across 4 reported transactions
- 2
Jonathan Thompson
$17,208.55 across 4 reported transactions
- 3
John Moenning
$13,912.46 across 6 reported transactions
- 4
Beth Israel Deaconess Medical Center
$5,296.23 across 6 reported transactions
- 5
Amol Saxena
$1,621.26 across 2 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Teleflex Medical Incorporated ranks #912 of 1,925 by total payments (top 47% by spend) but is notably more concentrated than that alone would suggest -- #209 of 1,838 by HHI (top 11% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Spirus Medical LLC : $6.9K total payments, HHI 7667
- GenBioPro, Inc. : $49.5K total payments, HHI 7570
- Preceptis Medical, Inc. : $60.6K total payments, HHI 7566
- UCB Biosciences Inc. : $16.7K total payments, HHI 7541
- Siesta Medical, Inc. : $19.1K total payments, HHI 7498
- Innovative Medical Products, Inc. : $22.8K total payments, HHI 7434
- Teleflex Medical Incorporated (this company) : $268.8K total payments, HHI 7395
- Aesculap Biologics, LLC : $5.2K total payments, HHI 7394
- Sequence LifeScience, Inc : $194.5K total payments, HHI 7391
- Elekta, Inc. : $3.2M total payments, HHI 7371
- Nanovis LLC : $47.0K total payments, HHI 7351
- Atrility Medical, Inc. : $712.50 total payments, HHI 7341
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Teleflex Medical Incorporated's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Teleflex Medical Incorporated.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Teleflex Medical Incorporated.
Showing 6 of 1,924 companies with CMS-reported payment data.
Joint Restoration Foundation, Inc.
Withings, Inc.
Advanced Bionics, LLC
B. Braun Interventional Systems Inc.
Creo Medical Inc.
Put this to use
Teleflex Medical Incorporated ranks #912 of 1,925 by all-tracks total payments, led by "Royalty or License".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Royalty or License" spend across every manufacturer, not just Teleflex Medical Incorporated. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.